This morning at the Atlanta Marriott Marquis in downtown Atlanta, UCB, a biopharmaceutical research company for immunology disorders had its annual sales conference. A panel of Rheumatoid Arthritis (RA) patients was invited to speak and inspire, motivate and connect UCB's international sales team with real people who have unique experiences to share. Each RA patient is different, yet listening to each was very moving...there wasn't a dry eye in the ballroom! I am so grateful to have met such strong and courageous friends during my advocacy journey, together we make a difference! The U.S. Food and Drug Administration (FDA) approved Cimzia, for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA)! This is a major milestone in technology to help cure rheumatoid arthritis. Congrats to everyone at UCB, you are all making a difference in the lives of others!
No comments:
Post a Comment